Nadja Ballin
Tuebingen, BW 72076, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and Survival.
Journal: Biology
Published: November 03, 2025
Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort.
Journal: Neuro-oncology advances
Published: February 16, 2025
Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion.
Journal: Frontiers in oncology
Published: November 13, 2024
Tumor sequencing before and after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: Genetic tumor characterization and clinical outcome.
Journal: Clinical and translational radiation oncology
Published: September 10, 2024
Dynamics of cell-free tumor DNA correlate with early MRI response during chemoradiotherapy in rectal cancer.
Journal: Radiation oncology (London, England)
Published: July 21, 2024
Post-Abortem Detection of a Pathogenic Somatic PIK3CA-Variant in an Abdominal Lymphangioma That Is Not Present in Cultured Amniotic Fluid Cells.
Journal: Prenatal diagnosis
Published: July 17, 2024
A solid-phase transfection platform for arrayed CRISPR screens.
Journal: Molecular systems biology
Published: January 13, 2021
A solid-phase transfection platform for arrayed CRISPR screens.
Journal: Molecular systems biology
Published: May 03, 2019
Genetical, clinical, and functional analysis of a large international cohort of patients with autosomal recessive congenital ichthyosis due to mutations in NIPAL4.
Journal: Human mutation
Published: March 23, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026